High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds

and in vitro compound-proteome interaction analysis for one of these compounds. Our compendium of drug-metabolome profiles can be used to rapidly query the MoAs of uncharacterized antimicrobial compounds and should be a useful resource for the drug discovery community.

High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds | Litlas